SCHEMBL3192575

SCHEMBL3192575

N#CC1(F)C=CC=CC1C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL379457 0.71
SCHEMBL22371152 0.71
SCHEMBL11613512 0.68
SCHEMBL28947732 0.68
SCHEMBL4696091 0.68
SCHEMBL13850114 0.66
SCHEMBL17099928 0.64
SCHEMBL22171383 0.64
SCHEMBL9618037 0.63 HSD11B1 (0.31)
SCHEMBL21970725 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7670613-B2 Androgen modulators PFIZER INC. (US) 2010-03-02 US disclosed
US-20100048517-A1 ANDROGEN MODULATORS PFIZER INC 2010-02-25 US disclosed
EP-1781598-A1 ANDROGEN MODULATORS Warner-Lambert Company LLC (US) 2007-05-09 EP disclosed
WO-2006006065-A1 ANDROGEN MODULATORS WARNER-LAMBERT COMPANY LLC (US) 2006-01-19 WO disclosed
US-20060009427-A1 4-(2-Cyano-cyclohexyloxy)-2-trifluoromethyl-benzonitrlle, a salt, or an isomer;selective androgen receptor modulators; decrease excess sebum secretions; stimulafnts of hair growth at higher rates of cosmetically acceptable hair growth in patients with alopecia; acne; skin disorders; prostate cancer WARNER-LAMBERT COMPANY LLC 2006-01-12 US disclosed